Here are three things to know.
- Hereditary angiodema is a rare, inherited blood disorder where the body does not make enough plasma protein called C1-esterase inhibitor. The disease can cause rapid swelling attacks of the limbs, face, intestinal tract and airway.
- CSL Behring’s drug, Haegarda, is the first self-administered C1 esterase inhibitor injected under the skin to prevent these swelling attacks before they occur.
- Haegarda contains a freeze-dried version of the plasma protein, derived from the plasma of U.S. organ donors.
More articles on supply chain:
Drug manufacturer, distributor shut down for producing unapproved medications
Sanofi CEO on SCOTUS’ biologics ruling: 3 takeaways
Whole Foods acquisition could move Amazon closer to pharmacies
